Valo Health, Inc., based in Lexington, Massachusetts, has appointed Chris Anagnostopoulos, PhD, C.Stat, as the Chief Causal AI Officer. This newly created position will focus on advancing Valo's human causal biology platform by utilizing human data and AI for drug discovery. Dr. Anagnostopoulos will be responsible for translating extensive real-world human data into causal insights that can enhance the drug discovery process. Valo's goal is to enhance their capabilities in this area to improve the drug development process further.